Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl(9CI) is a chemical compound belonging to the oxadiazole family, characterized by the molecular formula C5H5N3O2. It is recognized for its unique chemical structure and diverse pharmaceutical and biological activities, making it a promising building block for the synthesis of pharmaceutical compounds and a potential scaffold for the development of novel drug candidates in the field of medicinal chemistry.

164024-09-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 164024-09-3 Structure
  • Basic information

    1. Product Name: 1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl- (9CI)
    2. Synonyms: 1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl- (9CI);1,3,4-Oxadiazole-3-carboxaldehyde-5-Methyl;5-Methyl-1,3,4-oxadiazole-2-carbaldehyde;1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl-
    3. CAS NO:164024-09-3
    4. Molecular Formula: C4H4N2O2
    5. Molecular Weight: 112.08676
    6. EINECS: N/A
    7. Product Categories: ALDEHYDE
    8. Mol File: 164024-09-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 224.2±23.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.294±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: -2.21±0.10(Predicted)
    10. CAS DataBase Reference: 1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl- (9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl- (9CI)(164024-09-3)
    12. EPA Substance Registry System: 1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl- (9CI)(164024-09-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 164024-09-3(Hazardous Substances Data)

164024-09-3 Usage

Uses

Used in Pharmaceutical Industry:
1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl(9CI) is used as a building block for the synthesis of pharmaceutical compounds due to its unique chemical structure and potential pharmacological properties. It contributes to the development of novel drug candidates with improved therapeutic effects and reduced side effects.
Used in Medicinal Chemistry Research:
1,3,4-Oxadiazole-2-carboxaldehyde, 5-methyl(9CI) serves as a valuable scaffold for further research and development in medicinal chemistry. Its diverse biological activities and potential pharmacological properties make it an interesting target for exploring new therapeutic agents and advancing the understanding of drug action mechanisms.

Check Digit Verification of cas no

The CAS Registry Mumber 164024-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,0,2 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 164024-09:
(8*1)+(7*6)+(6*4)+(5*0)+(4*2)+(3*4)+(2*0)+(1*9)=103
103 % 10 = 3
So 164024-09-3 is a valid CAS Registry Number.

164024-09-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-methyl-1,3,4-oxadiazole-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names 5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXALDEHYDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:164024-09-3 SDS

164024-09-3Downstream Products

164024-09-3Relevant articles and documents

INTEGRASE INHIBITORS 3

-

Page/Page column 60, (2008/06/13)

The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 164024-09-3